Day 1 – October 15, 2025
Keynote Speech – Extracellular Vesicles in 2025: Shaping the Medicine of Tomorrow
Session 1 – Extracellular Vesicles: Recent Advances
- Functional roles of EVs in homeostasis and disease development
- EVs in intercellular communication: Molecular mechanisms and signaling pathways
- EVs as diagnostic biomarkers in cancer, neurodegeneration, and cardiovascular diseases
- Latest advancements in EV isolation, characterization, and engineering technologies
Session 2 – Mitochondria & Extracellular Vesicles: A Cross-Talk in Health & Disease
- Biogenesis and molecular signature of mitochondria-derived EVs
-
Functional interplay between EVs and mitochondrial dynamics
-
EVs as mediators of mitochondrial function and metabolic regulation
-
Role of EVs in oxidative stress, redox homeostasis, and iron metabolism
- Implications of mitochondrial EVs in ageing and rejuvenation: from mechanisms to therapeutic perspectives
Day 2 – October 16, 2025
Session 3 – Microbiota & Extracellular Vesicles: Implications for Human Health
-
Role of microbiota-derived EVs in microbiota-host interactions
-
EVs as biomarkers for gut dysbiosis and metabolic diseases
-
Microbiota-derived EVs in immune modulation and inflammatory diseases
-
Gut-brain axis: the role of microbiota-derived EVs in neurological disorders
-
Exogenous microRNAs, gut microbiota modulation, and therapeutic innovations
Session 4 – Clinical Applications of Mitochondria- and Microbiota-Derived EVs
-
Mitochondria-derived EVs in regenerative medicine and metabolic disorders
-
Targeting mitochondrial EVs for neurodegenerative and cardiovascular diseases
-
Microbiota-derived EVs as next-generation probiotics and personalized medicine tools
-
EV-based therapies in immune, inflammatory, and autoimmune diseases
-
Clinical potential of EVs in skin regeneration, wound healing, and ageing interventions
10 Minutes-Pitch: Start-ups, Industry & Investors Showcase
A dedicated session for emerging biotech companies, investors, and industry leaders to present innovative projects, cutting-edge technologies, and investment opportunities in the extracellular vesicle space.